Polyrizon (PLRZ) announced that it has received formal confirmation from the Hearings Advisor of the Office of the General Counsel of the Nasdaq Hearings Panel of The Nasdaq Stock Market that the Company has regained compliance with all applicable listing requirements.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PLRZ:
- Polyrizon Ltd. Announces Special General Meeting for September 2025
- Biotech Alert: Searches spiking for these stocks today
- Polyrizon Achieves Breakthrough in Allergy Blocker Study
- Polyrizon reports successful intranasal delivery of PL-14 Allergy Blocker
- Polyrizon retains Nasdaq listing following hearings panel